Court Orders Scientific Misconduct Labels Removed From Fisher's Work

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 4 No 5
Volume 4
Issue 5

WASHINGTON--Bernard Fisher, MD, Distinguished Service Professor of Surgery, University of Pittsburgh, has won a court order requiring that scientific misconduct labels be removed from citations of his papers in federal databases (Cancerlit and Medline).

WASHINGTON--Bernard Fisher, MD, Distinguished Service Professorof Surgery, University of Pittsburgh, has won a court order requiringthat scientific misconduct labels be removed from citations ofhis papers in federal databases (Cancerlit and Medline).

The labels were added at the insistence of the Office of ResearchIntegrity after last year's revelations of misconduct by a Montrealparticipant in NSABP trials headed by Dr. Fisher. The government,through faxes sent to distributors of the databases, will alsoapologize for the labels, stating that Dr. Fisher's own researchhas never been found to be at fault.

Recent Videos
Brett L. Ecker, MD, focused on the use of de-escalation therapy, which is gaining momentum in neuroendocrine tumors.
Immunotherapy options like CAR T-cell therapy and antigen-presenting cell-directed agents are currently being evaluated in the pancreatic cancer field.
Certain bridging therapies and abundant steroid use may complicate the T-cell collection process during CAR T therapy.
Pancreatic cancer is projected to become the second-leading cause of cancer-related deaths by 2030 in the United States.
2 experts are featured in this video
2 experts are featured in this video
2 experts are featured in this video
4 KOLs are featured in this series.
Related Content